This research report provides a comprehensive analysis of the Immuno-oncology Therapy market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Immuno-oncology Therapy market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Immuno-oncology Therapy, challenges faced by the industry, and potential opportunities for market players.
The global Immuno-oncology Therapy market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Immuno-oncology Therapy market presents opportunities for various stakeholders, including Hospitals, Ambulatory Surgical Center. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Immuno-oncology Therapy market. Additionally, the growing consumer demand present avenues for market expansion.
The global Immuno-oncology Therapy market was valued at US$ 1162.9 million in 2023 and is projected to reach US$ 1576.3 million by 2030, at a CAGR of 4.7% during the forecast period.
The market for immuno-oncology therapy is driven by the growing interest in personalized and targeted cancer treatments and the need for innovative therapies with fewer side effects. The market's growth is also influenced by the approval of new immuno-oncology drugs and ongoing research in cancer immunotherapy.
Key Features:
The research report on the Immuno-oncology Therapy market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Immuno-oncology Therapy market.
Market Overview: The report provides a comprehensive overview of the Immuno-oncology Therapy market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Monoclonal Antibodies, Immune Checkpoint Inhibitors), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Immuno-oncology Therapy market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Immuno-oncology Therapy market's trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Immuno-oncology Therapy market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Immuno-oncology Therapy market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Immuno-oncology Therapy market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Immuno-oncology Therapy market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Immuno-oncology Therapy, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Immuno-oncology Therapy market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Immuno-oncology Therapy market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
- Monoclonal Antibodies
- Immune Checkpoint Inhibitors
- Immune System Modulators
- Cancer Vaccines
Market segment by Application
- Hospitals
- Ambulatory Surgical Center
- Others
Global Immuno-oncology Therapy Market Segment Percentages, By Region and Country, 2023 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Major players covered
- Amgen
- AstraZeneca
- Bristol-Myers Squibb
- Eli-Lilly
- Roche
- GlaxoSmithKline
- Janssen Biotech
- Merck
- Novartis
- Pfizer
- Sanofi
- Spectrum Pharmaceuticals
- Takeda
- BioNTech SE
- Allogene Therapeutics
- IMAB-I-Mab Biopharma Co., Ltd.
- Arcus Biosciences
- Gritstone Oncology
- Autolus Therapeutics
- Rubius Therapeutics
Outline of Major Chapters:
Chapter 1: Introduces the definition of Immuno-oncology Therapy, market overview.
Chapter 2: Global Immuno-oncology Therapy market size in revenue.
Chapter 3: Detailed analysis of Immuno-oncology Therapy company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Immuno-oncology Therapy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Immuno-oncology Therapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Immuno-oncology Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Immuno-oncology Therapy Overall Market Size
2.1 Global Immuno-oncology Therapy Market Size: 2023 VS 2030
2.2 Global Immuno-oncology Therapy Market Size, Prospects & Forecasts: 2019-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Immuno-oncology Therapy Players in Global Market
3.2 Top Global Immuno-oncology Therapy Companies Ranked by Revenue
3.3 Global Immuno-oncology Therapy Revenue by Companies
3.4 Top 3 and Top 5 Immuno-oncology Therapy Companies in Global Market, by Revenue in 2023
3.5 Global Companies Immuno-oncology Therapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Immuno-oncology Therapy Players in Global Market
3.6.1 List of Global Tier 1 Immuno-oncology Therapy Companies
3.6.2 List of Global Tier 2 and Tier 3 Immuno-oncology Therapy Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Immuno-oncology Therapy Market Size Markets, 2023 & 2030
4.1.2 Monoclonal Antibodies
4.1.3 Immune Checkpoint Inhibitors
4.1.4 Immune System Modulators
4.1.5 Cancer Vaccines
4.2 By Type - Global Immuno-oncology Therapy Revenue & Forecasts
4.2.1 By Type - Global Immuno-oncology Therapy Revenue, 2019-2024
4.2.2 By Type - Global Immuno-oncology Therapy Revenue, 2025-2030
4.2.3 By Type - Global Immuno-oncology Therapy Revenue Market Share, 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Immuno-oncology Therapy Market Size, 2023 & 2030
5.1.2 Hospitals
5.1.3 Ambulatory Surgical Center
5.1.4 Others
5.2 By Application - Global Immuno-oncology Therapy Revenue & Forecasts
5.2.1 By Application - Global Immuno-oncology Therapy Revenue, 2019-2024
5.2.2 By Application - Global Immuno-oncology Therapy Revenue, 2025-2030
5.2.3 By Application - Global Immuno-oncology Therapy Revenue Market Share, 2019-2030
6 Sights by Region
6.1 By Region - Global Immuno-oncology Therapy Market Size, 2023 & 2030
6.2 By Region - Global Immuno-oncology Therapy Revenue & Forecasts
6.2.1 By Region - Global Immuno-oncology Therapy Revenue, 2019-2024
6.2.2 By Region - Global Immuno-oncology Therapy Revenue, 2025-2030
6.2.3 By Region - Global Immuno-oncology Therapy Revenue Market Share, 2019-2030
6.3 North America
6.3.1 By Country - North America Immuno-oncology Therapy Revenue, 2019-2030
6.3.2 US Immuno-oncology Therapy Market Size, 2019-2030
6.3.3 Canada Immuno-oncology Therapy Market Size, 2019-2030
6.3.4 Mexico Immuno-oncology Therapy Market Size, 2019-2030
6.4 Europe
6.4.1 By Country - Europe Immuno-oncology Therapy Revenue, 2019-2030
6.4.2 Germany Immuno-oncology Therapy Market Size, 2019-2030
6.4.3 France Immuno-oncology Therapy Market Size, 2019-2030
6.4.4 U.K. Immuno-oncology Therapy Market Size, 2019-2030
6.4.5 Italy Immuno-oncology Therapy Market Size, 2019-2030
6.4.6 Russia Immuno-oncology Therapy Market Size, 2019-2030
6.4.7 Nordic Countries Immuno-oncology Therapy Market Size, 2019-2030
6.4.8 Benelux Immuno-oncology Therapy Market Size, 2019-2030
6.5 Asia
6.5.1 By Region - Asia Immuno-oncology Therapy Revenue, 2019-2030
6.5.2 China Immuno-oncology Therapy Market Size, 2019-2030
6.5.3 Japan Immuno-oncology Therapy Market Size, 2019-2030
6.5.4 South Korea Immuno-oncology Therapy Market Size, 2019-2030
6.5.5 Southeast Asia Immuno-oncology Therapy Market Size, 2019-2030
6.5.6 India Immuno-oncology Therapy Market Size, 2019-2030
6.6 South America
6.6.1 By Country - South America Immuno-oncology Therapy Revenue, 2019-2030
6.6.2 Brazil Immuno-oncology Therapy Market Size, 2019-2030
6.6.3 Argentina Immuno-oncology Therapy Market Size, 2019-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Immuno-oncology Therapy Revenue, 2019-2030
6.7.2 Turkey Immuno-oncology Therapy Market Size, 2019-2030
6.7.3 Israel Immuno-oncology Therapy Market Size, 2019-2030
6.7.4 Saudi Arabia Immuno-oncology Therapy Market Size, 2019-2030
6.7.5 UAE Immuno-oncology Therapy Market Size, 2019-2030
7 Immuno-oncology Therapy Companies Profiles
7.1 Amgen
7.1.1 Amgen Company Summary
7.1.2 Amgen Business Overview
7.1.3 Amgen Immuno-oncology Therapy Major Product Offerings
7.1.4 Amgen Immuno-oncology Therapy Revenue in Global Market (2019-2024)
7.1.5 Amgen Key News & Latest Developments
7.2 AstraZeneca
7.2.1 AstraZeneca Company Summary
7.2.2 AstraZeneca Business Overview
7.2.3 AstraZeneca Immuno-oncology Therapy Major Product Offerings
7.2.4 AstraZeneca Immuno-oncology Therapy Revenue in Global Market (2019-2024)
7.2.5 AstraZeneca Key News & Latest Developments
7.3 Bristol-Myers Squibb
7.3.1 Bristol-Myers Squibb Company Summary
7.3.2 Bristol-Myers Squibb Business Overview
7.3.3 Bristol-Myers Squibb Immuno-oncology Therapy Major Product Offerings
7.3.4 Bristol-Myers Squibb Immuno-oncology Therapy Revenue in Global Market (2019-2024)
7.3.5 Bristol-Myers Squibb Key News & Latest Developments
7.4 Eli-Lilly
7.4.1 Eli-Lilly Company Summary
7.4.2 Eli-Lilly Business Overview
7.4.3 Eli-Lilly Immuno-oncology Therapy Major Product Offerings
7.4.4 Eli-Lilly Immuno-oncology Therapy Revenue in Global Market (2019-2024)
7.4.5 Eli-Lilly Key News & Latest Developments
7.5 Roche
7.5.1 Roche Company Summary
7.5.2 Roche Business Overview
7.5.3 Roche Immuno-oncology Therapy Major Product Offerings
7.5.4 Roche Immuno-oncology Therapy Revenue in Global Market (2019-2024)
7.5.5 Roche Key News & Latest Developments
7.6 GlaxoSmithKline
7.6.1 GlaxoSmithKline Company Summary
7.6.2 GlaxoSmithKline Business Overview
7.6.3 GlaxoSmithKline Immuno-oncology Therapy Major Product Offerings
7.6.4 GlaxoSmithKline Immuno-oncology Therapy Revenue in Global Market (2019-2024)
7.6.5 GlaxoSmithKline Key News & Latest Developments
7.7 Janssen Biotech
7.7.1 Janssen Biotech Company Summary
7.7.2 Janssen Biotech Business Overview
7.7.3 Janssen Biotech Immuno-oncology Therapy Major Product Offerings
7.7.4 Janssen Biotech Immuno-oncology Therapy Revenue in Global Market (2019-2024)
7.7.5 Janssen Biotech Key News & Latest Developments
7.8 Merck
7.8.1 Merck Company Summary
7.8.2 Merck Business Overview
7.8.3 Merck Immuno-oncology Therapy Major Product Offerings
7.8.4 Merck Immuno-oncology Therapy Revenue in Global Market (2019-2024)
7.8.5 Merck Key News & Latest Developments
7.9 Novartis
7.9.1 Novartis Company Summary
7.9.2 Novartis Business Overview
7.9.3 Novartis Immuno-oncology Therapy Major Product Offerings
7.9.4 Novartis Immuno-oncology Therapy Revenue in Global Market (2019-2024)
7.9.5 Novartis Key News & Latest Developments
7.10 Pfizer
7.10.1 Pfizer Company Summary
7.10.2 Pfizer Business Overview
7.10.3 Pfizer Immuno-oncology Therapy Major Product Offerings
7.10.4 Pfizer Immuno-oncology Therapy Revenue in Global Market (2019-2024)
7.10.5 Pfizer Key News & Latest Developments
7.11 Sanofi
7.11.1 Sanofi Company Summary
7.11.2 Sanofi Business Overview
7.11.3 Sanofi Immuno-oncology Therapy Major Product Offerings
7.11.4 Sanofi Immuno-oncology Therapy Revenue in Global Market (2019-2024)
7.11.5 Sanofi Key News & Latest Developments
7.12 Spectrum Pharmaceuticals
7.12.1 Spectrum Pharmaceuticals Company Summary
7.12.2 Spectrum Pharmaceuticals Business Overview
7.12.3 Spectrum Pharmaceuticals Immuno-oncology Therapy Major Product Offerings
7.12.4 Spectrum Pharmaceuticals Immuno-oncology Therapy Revenue in Global Market (2019-2024)
7.12.5 Spectrum Pharmaceuticals Key News & Latest Developments
7.13 Takeda
7.13.1 Takeda Company Summary
7.13.2 Takeda Business Overview
7.13.3 Takeda Immuno-oncology Therapy Major Product Offerings
7.13.4 Takeda Immuno-oncology Therapy Revenue in Global Market (2019-2024)
7.13.5 Takeda Key News & Latest Developments
7.14 BioNTech SE
7.14.1 BioNTech SE Company Summary
7.14.2 BioNTech SE Business Overview
7.14.3 BioNTech SE Immuno-oncology Therapy Major Product Offerings
7.14.4 BioNTech SE Immuno-oncology Therapy Revenue in Global Market (2019-2024)
7.14.5 BioNTech SE Key News & Latest Developments
7.15 Allogene Therapeutics
7.15.1 Allogene Therapeutics Company Summary
7.15.2 Allogene Therapeutics Business Overview
7.15.3 Allogene Therapeutics Immuno-oncology Therapy Major Product Offerings
7.15.4 Allogene Therapeutics Immuno-oncology Therapy Revenue in Global Market (2019-2024)
7.15.5 Allogene Therapeutics Key News & Latest Developments
7.16 IMAB-I-Mab Biopharma Co., Ltd.
7.16.1 IMAB-I-Mab Biopharma Co., Ltd. Company Summary
7.16.2 IMAB-I-Mab Biopharma Co., Ltd. Business Overview
7.16.3 IMAB-I-Mab Biopharma Co., Ltd. Immuno-oncology Therapy Major Product Offerings
7.16.4 IMAB-I-Mab Biopharma Co., Ltd. Immuno-oncology Therapy Revenue in Global Market (2019-2024)
7.16.5 IMAB-I-Mab Biopharma Co., Ltd. Key News & Latest Developments
7.17 Arcus Biosciences
7.17.1 Arcus Biosciences Company Summary
7.17.2 Arcus Biosciences Business Overview
7.17.3 Arcus Biosciences Immuno-oncology Therapy Major Product Offerings
7.17.4 Arcus Biosciences Immuno-oncology Therapy Revenue in Global Market (2019-2024)
7.17.5 Arcus Biosciences Key News & Latest Developments
7.18 Gritstone Oncology
7.18.1 Gritstone Oncology Company Summary
7.18.2 Gritstone Oncology Business Overview
7.18.3 Gritstone Oncology Immuno-oncology Therapy Major Product Offerings
7.18.4 Gritstone Oncology Immuno-oncology Therapy Revenue in Global Market (2019-2024)
7.18.5 Gritstone Oncology Key News & Latest Developments
7.19 Autolus Therapeutics
7.19.1 Autolus Therapeutics Company Summary
7.19.2 Autolus Therapeutics Business Overview
7.19.3 Autolus Therapeutics Immuno-oncology Therapy Major Product Offerings
7.19.4 Autolus Therapeutics Immuno-oncology Therapy Revenue in Global Market (2019-2024)
7.19.5 Autolus Therapeutics Key News & Latest Developments
7.20 Rubius Therapeutics
7.20.1 Rubius Therapeutics Company Summary
7.20.2 Rubius Therapeutics Business Overview
7.20.3 Rubius Therapeutics Immuno-oncology Therapy Major Product Offerings
7.20.4 Rubius Therapeutics Immuno-oncology Therapy Revenue in Global Market (2019-2024)
7.20.5 Rubius Therapeutics Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Immuno-oncology Therapy Market Opportunities & Trends in Global Market
Table 2. Immuno-oncology Therapy Market Drivers in Global Market
Table 3. Immuno-oncology Therapy Market Restraints in Global Market
Table 4. Key Players of Immuno-oncology Therapy in Global Market
Table 5. Top Immuno-oncology Therapy Players in Global Market, Ranking by Revenue (2023)
Table 6. Global Immuno-oncology Therapy Revenue by Companies, (US$, Mn), 2019-2024
Table 7. Global Immuno-oncology Therapy Revenue Share by Companies, 2019-2024
Table 8. Global Companies Immuno-oncology Therapy Product Type
Table 9. List of Global Tier 1 Immuno-oncology Therapy Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Immuno-oncology Therapy Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Immuno-oncology Therapy Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Immuno-oncology Therapy Revenue in Global (US$, Mn), 2019-2024
Table 13. By Type - Immuno-oncology Therapy Revenue in Global (US$, Mn), 2025-2030
Table 14. By Application ? Global Immuno-oncology Therapy Revenue, (US$, Mn), 2023 & 2030
Table 15. By Application - Immuno-oncology Therapy Revenue in Global (US$, Mn), 2019-2024
Table 16. By Application - Immuno-oncology Therapy Revenue in Global (US$, Mn), 2025-2030
Table 17. By Region ? Global Immuno-oncology Therapy Revenue, (US$, Mn), 2023 & 2030
Table 18. By Region - Global Immuno-oncology Therapy Revenue (US$, Mn), 2019-2024
Table 19. By Region - Global Immuno-oncology Therapy Revenue (US$, Mn), 2025-2030
Table 20. By Country - North America Immuno-oncology Therapy Revenue, (US$, Mn), 2019-2024
Table 21. By Country - North America Immuno-oncology Therapy Revenue, (US$, Mn), 2025-2030
Table 22. By Country - Europe Immuno-oncology Therapy Revenue, (US$, Mn), 2019-2024
Table 23. By Country - Europe Immuno-oncology Therapy Revenue, (US$, Mn), 2025-2030
Table 24. By Region - Asia Immuno-oncology Therapy Revenue, (US$, Mn), 2019-2024
Table 25. By Region - Asia Immuno-oncology Therapy Revenue, (US$, Mn), 2025-2030
Table 26. By Country - South America Immuno-oncology Therapy Revenue, (US$, Mn), 2019-2024
Table 27. By Country - South America Immuno-oncology Therapy Revenue, (US$, Mn), 2025-2030
Table 28. By Country - Middle East & Africa Immuno-oncology Therapy Revenue, (US$, Mn), 2019-2024
Table 29. By Country - Middle East & Africa Immuno-oncology Therapy Revenue, (US$, Mn), 2025-2030
Table 30. Amgen Company Summary
Table 31. Amgen Immuno-oncology Therapy Product Offerings
Table 32. Amgen Immuno-oncology Therapy Revenue (US$, Mn) & (2019-2024)
Table 33. Amgen Key News & Latest Developments
Table 34. AstraZeneca Company Summary
Table 35. AstraZeneca Immuno-oncology Therapy Product Offerings
Table 36. AstraZeneca Immuno-oncology Therapy Revenue (US$, Mn) & (2019-2024)
Table 37. AstraZeneca Key News & Latest Developments
Table 38. Bristol-Myers Squibb Company Summary
Table 39. Bristol-Myers Squibb Immuno-oncology Therapy Product Offerings
Table 40. Bristol-Myers Squibb Immuno-oncology Therapy Revenue (US$, Mn) & (2019-2024)
Table 41. Bristol-Myers Squibb Key News & Latest Developments
Table 42. Eli-Lilly Company Summary
Table 43. Eli-Lilly Immuno-oncology Therapy Product Offerings
Table 44. Eli-Lilly Immuno-oncology Therapy Revenue (US$, Mn) & (2019-2024)
Table 45. Eli-Lilly Key News & Latest Developments
Table 46. Roche Company Summary
Table 47. Roche Immuno-oncology Therapy Product Offerings
Table 48. Roche Immuno-oncology Therapy Revenue (US$, Mn) & (2019-2024)
Table 49. Roche Key News & Latest Developments
Table 50. GlaxoSmithKline Company Summary
Table 51. GlaxoSmithKline Immuno-oncology Therapy Product Offerings
Table 52. GlaxoSmithKline Immuno-oncology Therapy Revenue (US$, Mn) & (2019-2024)
Table 53. GlaxoSmithKline Key News & Latest Developments
Table 54. Janssen Biotech Company Summary
Table 55. Janssen Biotech Immuno-oncology Therapy Product Offerings
Table 56. Janssen Biotech Immuno-oncology Therapy Revenue (US$, Mn) & (2019-2024)
Table 57. Janssen Biotech Key News & Latest Developments
Table 58. Merck Company Summary
Table 59. Merck Immuno-oncology Therapy Product Offerings
Table 60. Merck Immuno-oncology Therapy Revenue (US$, Mn) & (2019-2024)
Table 61. Merck Key News & Latest Developments
Table 62. Novartis Company Summary
Table 63. Novartis Immuno-oncology Therapy Product Offerings
Table 64. Novartis Immuno-oncology Therapy Revenue (US$, Mn) & (2019-2024)
Table 65. Novartis Key News & Latest Developments
Table 66. Pfizer Company Summary
Table 67. Pfizer Immuno-oncology Therapy Product Offerings
Table 68. Pfizer Immuno-oncology Therapy Revenue (US$, Mn) & (2019-2024)
Table 69. Pfizer Key News & Latest Developments
Table 70. Sanofi Company Summary
Table 71. Sanofi Immuno-oncology Therapy Product Offerings
Table 72. Sanofi Immuno-oncology Therapy Revenue (US$, Mn) & (2019-2024)
Table 73. Sanofi Key News & Latest Developments
Table 74. Spectrum Pharmaceuticals Company Summary
Table 75. Spectrum Pharmaceuticals Immuno-oncology Therapy Product Offerings
Table 76. Spectrum Pharmaceuticals Immuno-oncology Therapy Revenue (US$, Mn) & (2019-2024)
Table 77. Spectrum Pharmaceuticals Key News & Latest Developments
Table 78. Takeda Company Summary
Table 79. Takeda Immuno-oncology Therapy Product Offerings
Table 80. Takeda Immuno-oncology Therapy Revenue (US$, Mn) & (2019-2024)
Table 81. Takeda Key News & Latest Developments
Table 82. BioNTech SE Company Summary
Table 83. BioNTech SE Immuno-oncology Therapy Product Offerings
Table 84. BioNTech SE Immuno-oncology Therapy Revenue (US$, Mn) & (2019-2024)
Table 85. BioNTech SE Key News & Latest Developments
Table 86. Allogene Therapeutics Company Summary
Table 87. Allogene Therapeutics Immuno-oncology Therapy Product Offerings
Table 88. Allogene Therapeutics Immuno-oncology Therapy Revenue (US$, Mn) & (2019-2024)
Table 89. Allogene Therapeutics Key News & Latest Developments
Table 90. IMAB-I-Mab Biopharma Co., Ltd. Company Summary
Table 91. IMAB-I-Mab Biopharma Co., Ltd. Immuno-oncology Therapy Product Offerings
Table 92. IMAB-I-Mab Biopharma Co., Ltd. Immuno-oncology Therapy Revenue (US$, Mn) & (2019-2024)
Table 93. IMAB-I-Mab Biopharma Co., Ltd. Key News & Latest Developments
Table 94. Arcus Biosciences Company Summary
Table 95. Arcus Biosciences Immuno-oncology Therapy Product Offerings
Table 96. Arcus Biosciences Immuno-oncology Therapy Revenue (US$, Mn) & (2019-2024)
Table 97. Arcus Biosciences Key News & Latest Developments
Table 98. Gritstone Oncology Company Summary
Table 99. Gritstone Oncology Immuno-oncology Therapy Product Offerings
Table 100. Gritstone Oncology Immuno-oncology Therapy Revenue (US$, Mn) & (2019-2024)
Table 101. Gritstone Oncology Key News & Latest Developments
Table 102. Autolus Therapeutics Company Summary
Table 103. Autolus Therapeutics Immuno-oncology Therapy Product Offerings
Table 104. Autolus Therapeutics Immuno-oncology Therapy Revenue (US$, Mn) & (2019-2024)
Table 105. Autolus Therapeutics Key News & Latest Developments
Table 106. Rubius Therapeutics Company Summary
Table 107. Rubius Therapeutics Immuno-oncology Therapy Product Offerings
Table 108. Rubius Therapeutics Immuno-oncology Therapy Revenue (US$, Mn) & (2019-2024)
Table 109. Rubius Therapeutics Key News & Latest Developments
List of Figures
Figure 1. Immuno-oncology Therapy Segment by Type in 2023
Figure 2. Immuno-oncology Therapy Segment by Application in 2023
Figure 3. Global Immuno-oncology Therapy Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Immuno-oncology Therapy Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Immuno-oncology Therapy Revenue, 2019-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Immuno-oncology Therapy Revenue in 2023
Figure 8. By Type - Global Immuno-oncology Therapy Revenue Market Share, 2019-2030
Figure 9. By Application - Global Immuno-oncology Therapy Revenue Market Share, 2019-2030
Figure 10. By Type - Global Immuno-oncology Therapy Revenue, (US$, Mn), 2023 & 2030
Figure 11. By Type - Global Immuno-oncology Therapy Revenue Market Share, 2019-2030
Figure 12. By Application - Global Immuno-oncology Therapy Revenue, (US$, Mn), 2023 & 2030
Figure 13. By Application - Global Immuno-oncology Therapy Revenue Market Share, 2019-2030
Figure 14. By Region - Global Immuno-oncology Therapy Revenue Market Share, 2019-2030
Figure 15. By Country - North America Immuno-oncology Therapy Revenue Market Share, 2019-2030
Figure 16. US Immuno-oncology Therapy Revenue, (US$, Mn), 2019-2030
Figure 17. Canada Immuno-oncology Therapy Revenue, (US$, Mn), 2019-2030
Figure 18. Mexico Immuno-oncology Therapy Revenue, (US$, Mn), 2019-2030
Figure 19. By Country - Europe Immuno-oncology Therapy Revenue Market Share, 2019-2030
Figure 20. Germany Immuno-oncology Therapy Revenue, (US$, Mn), 2019-2030
Figure 21. France Immuno-oncology Therapy Revenue, (US$, Mn), 2019-2030
Figure 22. U.K. Immuno-oncology Therapy Revenue, (US$, Mn), 2019-2030
Figure 23. Italy Immuno-oncology Therapy Revenue, (US$, Mn), 2019-2030
Figure 24. Russia Immuno-oncology Therapy Revenue, (US$, Mn), 2019-2030
Figure 25. Nordic Countries Immuno-oncology Therapy Revenue, (US$, Mn), 2019-2030
Figure 26. Benelux Immuno-oncology Therapy Revenue, (US$, Mn), 2019-2030
Figure 27. By Region - Asia Immuno-oncology Therapy Revenue Market Share, 2019-2030
Figure 28. China Immuno-oncology Therapy Revenue, (US$, Mn), 2019-2030
Figure 29. Japan Immuno-oncology Therapy Revenue, (US$, Mn), 2019-2030
Figure 30. South Korea Immuno-oncology Therapy Revenue, (US$, Mn), 2019-2030
Figure 31. Southeast Asia Immuno-oncology Therapy Revenue, (US$, Mn), 2019-2030
Figure 32. India Immuno-oncology Therapy Revenue, (US$, Mn), 2019-2030
Figure 33. By Country - South America Immuno-oncology Therapy Revenue Market Share, 2019-2030
Figure 34. Brazil Immuno-oncology Therapy Revenue, (US$, Mn), 2019-2030
Figure 35. Argentina Immuno-oncology Therapy Revenue, (US$, Mn), 2019-2030
Figure 36. By Country - Middle East & Africa Immuno-oncology Therapy Revenue Market Share, 2019-2030
Figure 37. Turkey Immuno-oncology Therapy Revenue, (US$, Mn), 2019-2030
Figure 38. Israel Immuno-oncology Therapy Revenue, (US$, Mn), 2019-2030
Figure 39. Saudi Arabia Immuno-oncology Therapy Revenue, (US$, Mn), 2019-2030
Figure 40. UAE Immuno-oncology Therapy Revenue, (US$, Mn), 2019-2030
Figure 41. Amgen Immuno-oncology Therapy Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 42. AstraZeneca Immuno-oncology Therapy Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 43. Bristol-Myers Squibb Immuno-oncology Therapy Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 44. Eli-Lilly Immuno-oncology Therapy Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 45. Roche Immuno-oncology Therapy Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 46. GlaxoSmithKline Immuno-oncology Therapy Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 47. Janssen Biotech Immuno-oncology Therapy Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 48. Merck Immuno-oncology Therapy Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 49. Novartis Immuno-oncology Therapy Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 50. Pfizer Immuno-oncology Therapy Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 51. Sanofi Immuno-oncology Therapy Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 52. Spectrum Pharmaceuticals Immuno-oncology Therapy Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 53. Takeda Immuno-oncology Therapy Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 54. BioNTech SE Immuno-oncology Therapy Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 55. Allogene Therapeutics Immuno-oncology Therapy Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 56. IMAB-I-Mab Biopharma Co., Ltd. Immuno-oncology Therapy Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 57. Arcus Biosciences Immuno-oncology Therapy Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 58. Gritstone Oncology Immuno-oncology Therapy Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 59. Autolus Therapeutics Immuno-oncology Therapy Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 60. Rubius Therapeutics Immuno-oncology Therapy Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
